Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

LIMNW
Liminatus Pharma, Inc. Warrants
stock NASDAQ Warrant

At Close
Jul 2, 2025 3:59:30 PM EDT
0.1601USD0.000%(+0.1601)93,655
0.00Bid   0.00Ask   0.0000Spread
Pre-market
Jul 3, 2025 8:38:30 AM EDT
0.1800USD+12.430%(+0.0199)10,000
After-hours
Jul 2, 2025 4:23:30 PM EDT
0.1800USD+12.430%(+0.0199)186,000
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrends
LIMNW Reddit Mentions
Subreddits
Limit Labels     

We have sentiment values and mention counts going back to 2017. The complete data set is available via the API.
Take me to the API
LIMNW Specific Mentions
As of Jul 5, 2025 2:35:32 AM EDT (<1 min. ago)
Includes all comments and posts. Mentions per user per ticker capped at one per hour.
10 days ago • u/SPAC_Time • r/SPACs • announcements_x_daily_discussion_for_tuesday_june • C
While almost no one was paying attention, deSPAC Liminatus Pharma ( LIMN LIMNW ) has been on a low float run the past couple of weeks. Iris Acquisition closed the business combination on May 1. On June 3, LIMN was $5.30. Closed at $26.67 today.
"[Immediately after giving effect to the redemption of 59,844 Iris Class A Shares in connection with the Business Combination](https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/tm2513673d1_8k.htm#:~:text=Immediately%20after%20giving%20effect%20to%20the%20redemption%20of%2059%2C844%20Iris%20Class%C2%A0A%20Shares%20in%20connection%20with%20the%20Business%20Combination), there were 114,633 public shares and 6,900,000 public warrants outstanding."
LIMN just filed [the S-1 registration statement to register shares underlying the warrants](https://www.sec.gov/Archives/edgar/data/1971387/000141057825001432/limn-20250331xs1.htm) today, so going to be some time before warrants can be exercised.
No news from LIMN since business combination closed. From the [prospectus for business combination, page 197](https://www.sec.gov/Archives/edgar/data/1971387/000110465925010605/tm2432198-7_424b3.htm):
"***Revenue***
To date, we have not generated any revenue from any sources, including from product sales, and **we do not expect to generate any revenue from the sale of products in the foreseeable future**. If our development efforts for our product candidates are successful and result in regulatory approval, or license agreements with third parties, we may generate revenue in the future from product sales. However, **there can be no assurance as to when we will generate such revenue, if at all**."
sentiment 0.95
10 days ago • u/SPAC_Time • r/pennystocks • limnw_is_the_most_undervalued_penny_stock_on_the • C
The market is *VERY* efficient, and there is a reason the warrants are only 38 cents, while the stock is at $27.
**THE WARRANTS CAN NOT BE EXERCISED**.
From the 424B3 final prospectus filed by Liminatus Pharma on February 27:
"We will not be obligated to deliver any ParentCo Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of ParentCo Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating thereto is current"
"**We are not registering the shares of ParentCo Common Stock issuable upon exercise of the warrants at this time. However, we have agreed that as soon as practicable, but in no event later than 30 days after the closing of the Business Combination**, we will use our commercially reasonable efforts to file with the SEC a registration statement covering the issuance, under the Securities Act, of the ParentCo Common Stock issuable upon exercise of the warrants, and we will use our commercially reasonable efforts to cause the same to become effective within 120 days after the closing of the Business Combination and to maintain the effectiveness of such registration statement **..."**
[https://www.sec.gov/Archives/edgar/data/1971387/000110465925010605/tm2432198-7\_424b3.htm](https://www.sec.gov/Archives/edgar/data/1971387/000110465925010605/tm2432198-7_424b3.htm) \- Page 217
***Today***, LIMN filed the [S-1 registration statement that registers the shares of LIMN common stock](https://www.sec.gov/Archives/edgar/data/1971387/000141057825001432/limn-20250331xs1.htm) that will be issued if/when LIMNW warrants are exercised.
That form will take some indefinite time to complete. It could be two weeks, or it could be two months.
Until that From S-1 is declared effective by the SEC, the warrants cannot be exercised. By the time the S-1 is declared effective, it is possible LIMN will have fallen back to $5 per share, where it was three weeks ago.
That is why the warrants are only 38 cents.
sentiment 0.96
10 days ago • u/SPAC_Time • r/SPACs • announcements_x_daily_discussion_for_tuesday_june • C
While almost no one was paying attention, deSPAC Liminatus Pharma ( LIMN LIMNW ) has been on a low float run the past couple of weeks. Iris Acquisition closed the business combination on May 1. On June 3, LIMN was $5.30. Closed at $26.67 today.
"[Immediately after giving effect to the redemption of 59,844 Iris Class A Shares in connection with the Business Combination](https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/tm2513673d1_8k.htm#:~:text=Immediately%20after%20giving%20effect%20to%20the%20redemption%20of%2059%2C844%20Iris%20Class%C2%A0A%20Shares%20in%20connection%20with%20the%20Business%20Combination), there were 114,633 public shares and 6,900,000 public warrants outstanding."
LIMN just filed [the S-1 registration statement to register shares underlying the warrants](https://www.sec.gov/Archives/edgar/data/1971387/000141057825001432/limn-20250331xs1.htm) today, so going to be some time before warrants can be exercised.
No news from LIMN since business combination closed. From the [prospectus for business combination, page 197](https://www.sec.gov/Archives/edgar/data/1971387/000110465925010605/tm2432198-7_424b3.htm):
"***Revenue***
To date, we have not generated any revenue from any sources, including from product sales, and **we do not expect to generate any revenue from the sale of products in the foreseeable future**. If our development efforts for our product candidates are successful and result in regulatory approval, or license agreements with third parties, we may generate revenue in the future from product sales. However, **there can be no assurance as to when we will generate such revenue, if at all**."
sentiment 0.95
10 days ago • u/SPAC_Time • r/pennystocks • limnw_is_the_most_undervalued_penny_stock_on_the • C
The market is *VERY* efficient, and there is a reason the warrants are only 38 cents, while the stock is at $27.
**THE WARRANTS CAN NOT BE EXERCISED**.
From the 424B3 final prospectus filed by Liminatus Pharma on February 27:
"We will not be obligated to deliver any ParentCo Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of ParentCo Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating thereto is current"
"**We are not registering the shares of ParentCo Common Stock issuable upon exercise of the warrants at this time. However, we have agreed that as soon as practicable, but in no event later than 30 days after the closing of the Business Combination**, we will use our commercially reasonable efforts to file with the SEC a registration statement covering the issuance, under the Securities Act, of the ParentCo Common Stock issuable upon exercise of the warrants, and we will use our commercially reasonable efforts to cause the same to become effective within 120 days after the closing of the Business Combination and to maintain the effectiveness of such registration statement **..."**
[https://www.sec.gov/Archives/edgar/data/1971387/000110465925010605/tm2432198-7\_424b3.htm](https://www.sec.gov/Archives/edgar/data/1971387/000110465925010605/tm2432198-7_424b3.htm) \- Page 217
***Today***, LIMN filed the [S-1 registration statement that registers the shares of LIMN common stock](https://www.sec.gov/Archives/edgar/data/1971387/000141057825001432/limn-20250331xs1.htm) that will be issued if/when LIMNW warrants are exercised.
That form will take some indefinite time to complete. It could be two weeks, or it could be two months.
Until that From S-1 is declared effective by the SEC, the warrants cannot be exercised. By the time the S-1 is declared effective, it is possible LIMN will have fallen back to $5 per share, where it was three weeks ago.
That is why the warrants are only 38 cents.
sentiment 0.96


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC